<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Molecular Cloning | Protocol 7 Print Version</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1251"><!--================== Designed and Developed by WriteDesign =================--><!--======================= Powered by RomeBlack, Inc. =======================--><!--=== Copyright 2000, 2001 Cold Spring Harbor Labs. All Rights Reserved. ===-->
<META content="" name=keywords>
<META 
content="Probes of high specific activities can be obtained using the Klenow fragment of E. coli DNA polymerase I to catalyze synthesis of a strand of DNA complementary to a synthetic oligonucleotide. A short primer is hybridized to an oligonucleotide template whose sequence is the complement of the desired radiolabeled probe. The primer is then extended using the Klenow fragment of E. coli DNA polymerase I to incorporate [&#945;-32P]dNTPs in a template-directed manner. After the reaction, the template and product are separated by denaturation, followed by electrophoresis through a polyacrylamide gel under denaturing conditions. With this method, it is possible to generate oligonucleotide probes that contain several radioactive atoms per molecule of oligonucleotide and to achieve specific activities as high as 2 x 1010 cpm/µg of probe." 
name=description>
<META content="MSHTML 5.50.4134.600" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff background=../izo/fon.gif>
<table width=600 border="0" cellspacing="0" cellpadding="0"><tr><td width=600><IMG height=49 hspace=4 src="../izo/logo_csh.gif" 
width=169 align=left vspace=4><IMG height=49 hspace=4 
src="../izo/print_header.gif" width=293 align=left vspace=4><BR 
clear=all><BR><FONT face="arial,verdana, helvetica" size=4><STRONG>Chapter 10, 
Protocol 7</STRONG></FONT><BR><BR clear=all><FONT face=arial,verdana,helvetica 
size=3><STRONG>Labeling of Synthetic Oligonucleotides Using the Klenow Fragment 
of<I> E. coli </I>DNA Polymerase I</STRONG></FONT><BR><BR><FONT 
face="arial,verdana, helvetica" size=2>Probes of high specific activities can be 
obtained using the Klenow fragment of <I>E. coli</I> DNA polymerase I to 
catalyze synthesis of a strand of DNA complementary to a synthetic 
oligonucleotide. A short primer is hybridized to an oligonucleotide template 
whose sequence is the complement of the desired radiolabeled probe. The primer 
is then extended using the Klenow fragment of <I>E. coli</I> DNA polymerase I to 
incorporate [<IMG src="../izo/alpha.gif" border=0>-<SUP>32</SUP>P]dNTPs in a 
template-directed manner. After the reaction, the template and product are 
separated by denaturation, followed by electrophoresis through a polyacrylamide 
gel under denaturing conditions. With this method, it is possible to generate 
oligonucleotide probes that contain several radioactive atoms per molecule of 
oligonucleotide and to achieve specific activities as high as 2 x 
10<SUP>10</SUP> cpm/µg of probe.</FONT> <BR><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD width=700><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" 
      width=11 border=0><FONT face=arial,verdana,helvetica 
      size=2><STRONG>CAUTION</STRONG></FONT><BR><IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0><FONT 
      face="arial,verdana, helvetica" size=2> <STRONG>RECIPE</STRONG></FONT> 
  </TD></TR></TBODY></TABLE><BR><BR><FONT face=arial,verdana,helvetica 
size=3><STRONG>MATERIALS</STRONG></FONT><BR><BR>
<TABLE cellPadding=0 cellborder="0">
  <TBODY>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Buffers and Solutions</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Formamide 
      loading buffer </FONT><IMG height=11 alt=caution hspace=4 
      src="../izo/triangle.gif" width=12 border=0><IMG height=12 alt="" 
      hspace=4 src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>10x Klenow 
      buffer</FONT> <IMG height=12 alt="" hspace=4 src="../izo/circle.gif" 
      width=12 border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Enzymes and Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Klenow 
      fragment of <I>E. coli</I> DNA polymerase I</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Nucleic Acids and Oligonucleotides</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" 
      size=2>Oligonucleotide primer</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Purify the 
      primer as described in <A href="01.htm">Chapter 
      10, Protocol 1 </A>. To ensure efficient radiolabeling, the primer should 
      be in three- to tenfold molar excess over the template DNA in the reaction 
      mixture.</I> </FONT></TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Template 
      oligonucleotide</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Purify the 
      template as described in <A href="01.htm">Chapter 
      10, Protocol 1 </A>. The sequence of the oligonucleotide template 
      <I>should be the complement</I> of the desired radiolabeled probe.</I> 
      </FONT></TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Radioactive Compounds</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>[<IMG 
      src="../izo/alpha.gif" border=0>-<SUP>32</SUP>P]dNTPs</FONT> <IMG 
      height=11 alt=caution hspace=4 src="../izo/triangle.gif" width=12 
      border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>To keep the 
      substrate concentration high, perform the extension reaction in as small a 
      volume as possible. Thus, it is best to use radiolabeled dNTPs supplied in 
      ethanol/H<SUB>2</SUB>O rather than those supplied in buffered aqueous 
      solvents. Appropriate volumes of the ethanolic [<IMG 
      src="../izo/alpha.gif" border=0>-<SUP>32</SUP>P]dNTPs can be mixed and 
      evaporated to dryness in the microfuge tube that will be used to carry out 
      the reaction.</I> </FONT></TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Additional Reagents</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 9 of this 
      protocol requires reagents listed in <A href="../05/12.htm">Chapter 
      5, Protocol 12 </A>.</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 
  border=0></TD></TR></TBODY></TABLE><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" 
size=3><STRONG>METHOD</STRONG></FONT> <BR><FONT face="arial,verdana, helvetica" 
color=#000000 size=2>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Transfer to a 
  microfuge tube the calculated amounts of [<IMG src="../izo/alpha.gif" 
  border=0>-<SUP>32</SUP>P]dNTPs necessary to achieve the desired specific 
  activity and sufficient to allow complete synthesis of all template 
  strands.<BR><I>The concentration of dNTPs should not drop below 1 µM at any 
  stage during the reaction. To keep the substrate concentration high, the 
  extension reaction should be carried out in as small a volume as possible.</I> 
  </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Add to the tube 
  the appropriate amounts of oligonucleotide primer and template 
  oligonucleotide.<BR><I>To ensure efficient radiolabeling, the primer should be 
  in three- to tenfold molar excess over the template DNA in the reaction 
  mixture.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Add 0.1 volume 
  of 10x Klenow buffer to the tube. Mix the reagents well. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Add 2-4 units 
  of the Klenow fragment per 5 µl of reaction volume. Mix well. Incubate the 
  reaction for 2-3 hours at 14°C.<BR><I>If desired, the progress of the reaction 
  may be monitored by removing small (0.1 µl) aliquots and measuring the 
  proportion of radioactivity that has become precipitable with 10% 
  trichloroacetic acid (TCA).</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Prepare a 
  denaturing polyacrylamide gel (as described in <A href="../12/08.htm">Chapter 
  12, Protocol 8</A>) of the appropriate concentration (see table). Dilute the 
  reaction mixture with an equal volume of formamide-loading buffer, heat the 
  mixture to 80°C for 3 minutes, and load the entire sample on the 
  gel.<BR><BR><B>Percent Polyacrylamide Required to Resolve Oligonucleotides</B> 

  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2><B>Length of 
        Oligonucleotide</B></FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
        size=2><B>Polyacrylamide (%)</B></FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>12-15 
        nucleotides</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>20</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>25-35 
        nucleotides</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>15</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>35-45 
        nucleotides</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>12</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>45-70 
        nucleotides</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica 
    size=2>10</FONT></TD></TR></TBODY></TABLE></FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Following 
  electrophoresis, disassemble the electrophoresis apparatus, leaving the 
  polyacrylamide gel attached to one of the glass plates (for details, please 
  see Chapter 12, Protocol 11). </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Wrap the gel 
  and its backing plate in Saran Wrap. Note the position of the tracking dyes 
  and use a hand-held minimonitor to check the amount of radioactivity in the 
  region of the gel that should contain the oligonucleotide. Attach a set of 
  adhesive dot labels, marked with either very hot radioactive ink or 
  phosphorescent spots, around the edge of the sample on the Saran Wrap. Cover 
  the radioactive dots with Scotch Tape to prevent contaminating the film holder 
  or intensifying screen with the radioactive ink. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Expose the gel 
  to autoradiographic film.<BR><I>Usually, the amount of radioactivity 
  incorporated into the probe is so great that the time needed to obtain an 
  image on film is no more than a few seconds.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>After 
  developing the film, align the images of the radioactive ink with the 
  radioactive marks on the labels, and locate the position of the probe in the 
  gel. Excise the band and recover the radioactive oligonucleotide as described 
  in <A href="../05/12.htm">Chapter 
  5, Protocol 12 </A>. </FONT></LI></OL></FONT><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>RECIPES</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/circle.gif" width=12 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>EDTA</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare EDTA at 0.5 M 
      (pH 8.0): Add 186.1 g of disodium EDTA2H<SUB>2</SUB>O to 800 ml of 
      H<SUB>2</SUB>O. Stir vigorously on a magnetic stirrer. Adjust the pH to 
      8.0 with NaOH (approx. 20 g of NaOH pellets). Dispense into aliquots and 
      sterilize by autoclaving. The disodium salt of EDTA will not go into 
      solution until the pH of the solution is adjusted to approx. 8.0 by the 
      addition of NaOH.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Formamide</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Deionize the formamide by 
      stirring on a magnetic stirrer with Dowex XG8 mixed bed resin for 1 hour 
      and filtering it twice through Whatman No. 1 paper. Store deionized 
      formamide in small aliquots under nitrogen at 
-70°C.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Formamide Loading Buffer</STRONG></FONT> 
  </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>80% (w/v) deionized 
      formamide</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10 mM EDTA (pH 
    8.0)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>1 mg/ml xylene cyanol 
      FF</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>1 mg/ml bromophenol 
      blue</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Purchase a distilled 
      deionized preparation of formamide and store in small aliquots under 
      nitrogen at -20°C.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Klenow Buffer</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>0.4 M potassium phosphate 
      (pH 7.5)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>66 mM 
      MgCl<SUB>2</SUB></FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10 mM <IMG 
      src="../izo/beta.gif" border=0>-mermercaptoethanol</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10x 
  stock.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Phosphate Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Gomori buffers, the most commonly used phosphate buffers, consist of a 
      mixture of monobasic dihydrogen phosphate and dibasic monohydrogen 
      phosphate. By varying the amount of each salt, a range of buffers can be 
      prepared that buffer well between pH 5.8 and pH 8.0 (please see the tables 
      below). Phosphates have a very high buffering capacity and are highly 
      soluble in water. However, they have a number of potential 
      disadvantages:</P>
      <P>
      <TABLE>
        <TBODY>
        <TR>
          <TD></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>Phosphates inhibit 
            many enzymatic reactions and procedures that are the foundation of 
            molecular cloning, including cleavage of DNA by many restriction 
            enzymes, ligation of DNA, and bacterial transformation.</FONT></TD></TR>
        <TR>
          <TD></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>Because phosphates 
            precipitate in ethanol, it is not possible to precipitate DNA and 
            RNA from buffers that contain significant quantities of phosphate 
            ions.</FONT> </TD></TR>
        <TR>
          <TD></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>Phosphates sequester 
            divalent cations such as Ca<SUP>2+</SUP> and Mg<SUP>2+</SUP>.</FONT> 
          </TD></TR></TBODY></TABLE>
      <TABLE>
        <TBODY>
        <TR>
          <TD><IMG height=412 src="../izo/phos_a.gif" width=339 
        border=0></TD></TR>
        <TR>
          <TD><IMG height=414 src="../izo/phos_b.gif" width=338 
        border=0></TD></TR></TBODY></TABLE></FONT></P></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Potassium Phosphate</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Phosphate 
    Buffers</FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;     helvetica" size=3><STRONG>CAUTIONS</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" width=11 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>&szlig;-Mercaptoethanol </STRONG></FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">&szlig;-Mercaptoethanol (2-Mercaptoethanol) 
      HOCH<SUB>2</SUB>CH<SUB>2</SUB>SH may be fatal if inhaled or absorbed 
      through the skin and is harmful if ingested. High concentrations are 
      extremely destructive to the mucous membranes, upper respiratory tract, 
      skin, and eyes. &szlig;-Mercaptoethanol has a very foul odor. Wear appropriate 
      gloves and safety glasses. Always use in a chemical fume hood. 
  </FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>Formamide </STRONG></FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">Formamide is teratogenic. The vapor is irritating to the eyes, 
      skin, mucous membranes, and upper respiratory tract. It may be harmful by 
      inhalation, ingestion, or skin absorption. Wear appropriate gloves and 
      safety glasses. Always use in a chemical fume hood when working with 
      concentrated solutions of formamide. Keep working solutions covered as 
      much as possible. </FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>Radioactive substances</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">Radioactive substances: When planning an experiment that involves 
      the use of radioactivity, consider the physico-chemical properties of the 
      isotope (half-life, emission type, and energy), the chemical form of the 
      radioactivity, its radioactive concentration (specific activity), total 
      amount, and its chemical concentration. Order and use only as much as 
      needed. Always wear appropriate gloves, lab coat, and safety goggles when 
      handling radioactive material. X-rays and gamma rays are electromagnetic 
      waves of very short wavelengths either generated by technical devices or 
      emitted by radioactive materials. They might be emitted isotropically from 
      the source or may be focused into a beam. Their potential dangers depend 
      on the time period of exposure, the intensity experienced, and the 
      wavelengths used. Be aware that appropriate shielding is usually made of 
      lead or other similar material. The thickness of the shielding is 
      determined by the energy(s) of the X-rays or gamma rays. Consult the local 
      safety office for further guidance in the appropriate use and disposal of 
      radioactive materials. Always monitor thoroughly after using 
      radioisotopes. A convenient calculator to perform routine radioactivity 
      calculations can be found at: <A target=_blank 
      href="http://www.graphpad.com/calculators/radcalc.cfm">http://www.graphpad.com/calculators/radcalc.cfm</A>. 
      </FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>REFERENCES</STRONG> 
</FONT><BR>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Studencki A.B. 
  and Wallace R.B. 1984. Allele-specific hybridization using oligonucleotide 
  probes of very high specific activity: Discrimination of the human <IMG 
  src="../izo/beta.gif" border=0><SUP>A</SUP>- and <IMG 
  src="../izo/beta.gif" border=0><SUP>S</SUP>-globin genes. <I>DNA</I> 3:7-15. 
  </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Ullrich A., 
  Berman C.H., Dull T.J., Gray A., and Lee J.M. 1984. Isolation of the human 
  insulin-like growth factor I gene using a single synthetic DNA probe. <I>EMBO 
  J.</I> 3:361-364. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Wetmur J.G. 
  1991. DNA probes: Applications of the principles of nucleic acid 
  hybridization. <I>Crit. Rev. Biochem. Mol. Biol.</I> 26:227-259. 
</FONT></LI></OL><BR><BR><BR><BR><BR><FONT face=Arial,Verdana,Helvetica 
size=1><STRONG>Copyright © 2000 by Cold Spring Harbor Laboratory Press. All 
rights reserved.</STRONG><BR>No part of these pages, either text or image may be 
used for any purpose other than personal use. Therefore, reproduction 
modification, storage in a retrieval system or retransmission, in any form or by 
any means, electronic, mechanical, or otherwise, for reasons other than personal 
use, is strictly prohibited without prior written 
permission.</FONT><BR><BR>
</td></tr></table>
</BODY></HTML>
